2AB-27159-14205
5 vaccinations
5 coded responses
57 check-ins
5 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 229 / VA
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Pfizer-BioNTech
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-04
- 2021-01-06
- 2021-01-13
-
2021-01-20
Dose 2 — Pfizer-BioNTech
- 2021-01-20
-
2021-01-21
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-01-22
- 2021-01-23
- 2021-01-24
- 2021-01-25
- 2021-01-26
- 2021-01-27
-
2021-02-03
Survey response — day 14, dose 2MedDRA: Fatigue, Flushing, Headache, Pharyngeal disorder — Feeling: Good · Be unable to do your normal daily activitiesFree text: Headache, flushing, nasal pharyngeal irritation, fatigue -all episodiccomes and goes, and feel fine in between. Good day, not as good day. Like mild version of symptoms I had in April. Never fever or cough, so not tested.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-02-10
Survey response — day 21, dose 2MedDRA: Fatigue, Headache, Pharyngeal disorder — Feeling: FairFree text: Continuing episodic headache, fatigue, nasopharyngeal irritationMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-17
- 2021-02-24
- 2021-03-03
- 2021-04-21
-
2021-07-21
Survey response — 6 months, dose 2MedDRA: Migraine, Pre-existing disease — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Worsened migrainous episodesMedDRA releases: 2024-11 · check-in free text available
-
2021-07-21
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professional1 call case(s)
- 2021-07-27
-
2021-10-02
Dose 3 — Pfizer-BioNTech
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-16
- 2021-10-23
- 2021-10-30
- 2021-11-06
- 2021-11-13
- 2022-01-01
-
2022-04-02
Survey response — 6 months, dose 3MedDRA: Nasal congestion, Nasopharyngitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Covid symptoms consisting of bad head cold and lots of nasopharyngeal congestion in Jan.MedDRA releases: 2024-11 · check-in free text available
-
2022-05-21
Dose 4 — Moderna
- 2022-05-21
-
2022-05-22
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-05-24
-
2022-05-25
Health check-in — days 1–6 daily, dose 4Feeling: Good · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-05-26
- 2022-05-27
- 2022-05-28
- 2022-06-04
- 2022-06-11
- 2022-06-18
-
2022-06-25
Survey response — day 35, dose 4MedDRA: Bursitis, Medical counselling — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Hip bursitis · Healthcare visit (other): Consulted relative who is orthopedic surgeon and put on meloxicamMedDRA releases: 2024-11 · check-in free text available
-
2022-06-25
Report sent to call center — day 35, dose 4Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2022-06-28
- 2022-06-28
- 2022-07-02
- 2022-08-20
-
2022-09-12
Dose 5 — Pfizer-BioNTech
- 2022-09-14
- 2022-09-17
- 2022-09-19
- 2022-09-26
- 2022-10-03
- 2022-10-10
- 2022-10-17
- 2022-10-24
- 2022-12-12
- 2023-03-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Pfizer-BioNTech | |
| 2 | 2021-01-20 | Pfizer-BioNTech | |
| 3 | 2021-10-02 | Pfizer-BioNTech | No |
| 4 | 2022-05-21 | Moderna | No |
| 5 | 2022-09-12 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 unsuccessful
Free text
Release 3 — day 14, dose 2
Symptoms: Headache, flushing, nasal pharyngeal irritation, fatigue -all episodiccomes and goes, and feel fine in between. Good day, not as good day. Like mild version of symptoms I had in April. Never fever or cough, so not tested.
Release 4 — day 21, dose 2
Symptoms: Continuing episodic headache, fatigue, nasopharyngeal irritation
Release 9 — 6 months, dose 2
Symptoms: Worsened migrainous episodes
Release 11 — 6 months, dose 3
Symptoms: Covid symptoms consisting of bad head cold and lots of nasopharyngeal congestion in Jan.
Release 12 — day 35, dose 4
Symptoms: Hip bursitis
Healthcare visit (other): Consulted relative who is orthopedic surgeon and put on meloxicam
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Medical counselling | · | · | ✓ |
| SD | Bursitis | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Flushing | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Pharyngeal disorder | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release